Study CB-839 in Combination With Nivolumab in Patients With Melanoma ccRCC and NSCLC
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Clear Cell Renal Cell Carcinoma
Age: Between 18 - 80 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required